Gufic Biosciences
Gufic Biosciences Share Price Chart
Gufic Biosciences last traded at ₹416.30 (2026-10-13). Over the past month the stock moved -2.1%, three months the stock moved +30.9%, year the stock moved +12.7%. Its closing range over 52 weeks is ₹279.25 – ₹446.70, with the latest close 6.8% below the high.
Closing prices up to 2026-10-13.
About Gufic Biosciences
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Business Segments 1) Domestic Branded Business: The company develops pharmaceutical formulations in various forms, including injectables, syrups, ointments, lotions, and herbal products. It serves 15+ therapeutic areas, including critical care, infertility, nutraceuticals, etc with a portfolio of 100+ products, 200+ SKUs, and a network of 30,000+ prescribers. It is one of the largest manufacturers of Lyophilized Injections in India. The company aims to expand into Biologicals and Immuno-Oncology. [1] [2]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Gufic Biosciences reported sales of ₹261.00 crore (+16.5%) and net profit of ₹22.00 crore (+69.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 261.00 | 47.00 | 18.00 | 22.00 | 2.22 |
| Mar 2026 | 252.00 | 47.00 | 19.00 | 22.00 | 2.18 |
| Dec 2025 | 231.00 | 33.00 | 14.00 | 12.00 | 1.24 |
| Sep 2025 | 237.00 | 38.00 | 16.00 | 17.00 | 1.68 |
| Jun 2025 | 224.00 | 33.00 | 15.00 | 13.00 | 1.30 |
| Mar 2025 | 205.00 | 26.00 | 13.00 | 8.00 | 0.77 |
| Dec 2024 | 208.00 | 34.00 | 16.00 | 19.00 | 1.93 |
| Sep 2024 | 204.00 | 39.00 | 19.00 | 22.00 | 2.17 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -5.1% | +3.0% | +5.1% | +10.3% | +16.2% | +11.1% | +22.9% | +16.5% |
| Operating profit growth | +0.0% | -5.6% | -23.5% | -8.3% | -2.6% | -2.9% | +80.8% | +42.4% |
| Net profit growth | -4.3% | -13.6% | -60.0% | -38.1% | -22.7% | -36.8% | +175.0% | +69.2% |
| EPS growth | -9.2% | -13.1% | -61.5% | -37.5% | -22.6% | -35.8% | +183.1% | +70.8% |
| OPM % | 19.0% | 16.0% | 13.0% | 15.0% | 16.0% | 14.0% | 19.0% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Gufic Biosciences reported sales of ₹944.00 crore (+15.1%) and net profit of ₹64.00 crore (-8.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 944.00 | 151.00 | 16.00 | 64.00 | 6.40 |
| Mar 2025 | 820.00 | 135.00 | 16.00 | 70.00 | 6.97 |
| Mar 2024 | 807.00 | 148.00 | 18.00 | 86.00 | 8.59 |
| Mar 2023 | 691.00 | 135.00 | 20.00 | 80.00 | 8.22 |
| Mar 2022 | 779.00 | 148.00 | 19.00 | 96.00 | 9.89 |
| Mar 2021 | 488.00 | 84.00 | 17.00 | 44.00 | 5.68 |
| Mar 2020 | 379.00 | 52.00 | 14.00 | 23.00 | 2.92 |
| Mar 2019 | 351.00 | 46.00 | 13.00 | 22.00 | 2.82 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +14.7% | +8.0% | +28.8% | +59.6% | -11.3% | +16.8% | +1.6% | +15.1% |
| Operating profit growth | +17.9% | +13.0% | +61.5% | +76.2% | -8.8% | +9.6% | -8.8% | +11.9% |
| Net profit growth | +37.5% | +4.5% | +91.3% | +118.2% | -16.7% | +7.5% | -18.6% | -8.6% |
| EPS growth | +32.4% | +3.5% | +94.5% | +74.1% | -16.9% | +4.5% | -18.9% | -8.2% |
| OPM % | 13.0% | 14.0% | 17.0% | 19.0% | 20.0% | 18.0% | 16.0% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Gufic Biosciences.
Get Free AI Stock Analysis FREE →Latest News
-
Gufic Biosciences surges on getting nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
-
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
Frequently Asked Questions
What is Gufic Biosciences's current stock price?
Gufic Biosciences shares were last quoted at ₹416.30 (+2.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Gufic Biosciences?
Gufic Biosciences has a price-to-earnings (P/E) ratio of 57.77 and a price-to-book (P/B) ratio of 6.17. The industry P/E is 53.33.
What is the 52-week high and low of Gufic Biosciences?
The 52-week high of Gufic Biosciences is ₹466.05 and the 52-week low is ₹267.50.
What is the market cap of Gufic Biosciences?
The market capitalisation of Gufic Biosciences is about ₹4,240.95 crore.
How did Gufic Biosciences perform in its latest quarterly results?
In the latest quarter (Jun 2026), Gufic Biosciences reported sales of ₹261.00 crore (+16.5%) and net profit of ₹22.00 crore (+69.2%), compared with the same quarter last year.
Is Gufic Biosciences a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Gufic Biosciences has a 3-year ROE of 13.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Gufic Biosciences?
Promoters hold about 72.50% of Gufic Biosciences.
Which sector does Gufic Biosciences belong to?
Gufic Biosciences belongs to the Pharmaceuticals & Drugs sector.